Rami Kantor

6.1k total citations · 1 hit paper
141 papers, 3.6k citations indexed

About

Rami Kantor is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Rami Kantor has authored 141 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Infectious Diseases, 98 papers in Virology and 25 papers in Epidemiology. Recurrent topics in Rami Kantor's work include HIV Research and Treatment (98 papers), HIV/AIDS Research and Interventions (96 papers) and HIV/AIDS drug development and treatment (80 papers). Rami Kantor is often cited by papers focused on HIV Research and Treatment (98 papers), HIV/AIDS Research and Interventions (96 papers) and HIV/AIDS drug development and treatment (80 papers). Rami Kantor collaborates with scholars based in United States, Kenya and Israel. Rami Kantor's co-authors include David Katzenstein, Robert W. Shafer, Ricardo Camacho, Jonathan Schapiro, Allison DeLong, Anne–Mieke Vandamme, Soo‐Yon Rhee, Philip A. Chan, Paul Sandstrom and Diane Bennett and has published in prestigious journals such as JAMA, Nucleic Acids Research and Bioinformatics.

In The Last Decade

Rami Kantor

130 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

2009 731 citations Diane Bennett, Rami Kantor et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rami Kantor United States	30	3.0k	2.7k	586	367	161	141	3.6k
Diane Descamps France	28	3.2k 1.1×	1.5k 0.6×	676 1.2×	389 1.1×	245 1.5×	136	3.9k
Daniela Moïsi Canada	27	2.4k 0.8×	2.2k 0.8×	654 1.1×	245 0.7×	102 0.6×	68	2.6k
Chris Verhofstede Belgium	31	1.8k 0.6×	1.9k 0.7×	600 1.0×	260 0.7×	103 0.6×	101	2.7k
Diane Descamps France	35	3.3k 1.1×	3.1k 1.1×	693 1.2×	283 0.8×	226 1.4×	140	3.8k
Annemarie M. J. Wensing Netherlands	29	1.9k 0.6×	1.6k 0.6×	578 1.0×	262 0.7×	119 0.7×	99	2.6k
Charlotte Charpentier France	24	1.4k 0.5×	1.2k 0.4×	439 0.7×	250 0.7×	101 0.6×	117	1.9k
Sodsai Tovanabutra United States	28	1.5k 0.5×	1.4k 0.5×	765 1.3×	266 0.7×	95 0.6×	102	2.4k
Sharon Cassol United States	27	1.4k 0.5×	1.3k 0.5×	699 1.2×	213 0.6×	78 0.5×	48	2.2k
Gert U. van Zyl South Africa	27	1.7k 0.6×	1.3k 0.5×	444 0.8×	162 0.4×	50 0.3×	122	2.0k
Nicole Ngo‐Giang‐Huong Thailand	25	1.9k 0.6×	1.7k 0.6×	752 1.3×	150 0.4×	205 1.3×	102	2.6k

Countries citing papers authored by Rami Kantor

Since Specialization

Citations

This map shows the geographic impact of Rami Kantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rami Kantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rami Kantor more than expected).

Fields of papers citing papers by Rami Kantor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rami Kantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rami Kantor. The network helps show where Rami Kantor may publish in the future.

Co-authorship network of co-authors of Rami Kantor

This figure shows the co-authorship network connecting the top 25 collaborators of Rami Kantor. A scholar is included among the top collaborators of Rami Kantor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rami Kantor. Rami Kantor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Diaz, José E., Soya S. Sam, Rami Kantor, et al.. (2024). Challenges and Opportunities with at-Home Blood Collection for HIV-1 Viral Load Monitoring among Sexual Minoritized Men who use Stimulants. AIDS and Behavior. 28(11). 3809–3818. 1 indexed citations

Howison, Mark, Fizza S. Gillani, Vlad Novitsky, et al.. (2023). An Automated Bioinformatics Pipeline Informing Near-Real-Time Public Health Responses to New HIV Diagnoses in a Statewide HIV Epidemic. Viruses. 15(3). 737–737. 7 indexed citations

Aung, Su, et al.. (2023). Characterization of HIV-Related Stigma in Myanmar. AIDS and Behavior. 27(8). 2751–2762. 3 indexed citations

Novitsky, Vlad, Winstone Nyandiko, Rachel Vreeman, et al.. (2023). Added Value of Next Generation Sequencing in Characterizing the Evolution of HIV-1 Drug Resistance in Kenyan Youth. Viruses. 15(7). 1416–1416. 3 indexed citations

Beckwith, Curt G., Akarsh Manne, Vladimir Novitsky, et al.. (2021). HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C.. AIDS Research and Human Retroviruses. 37(12). 903–912. 1 indexed citations

Beckwith, Curt G., Joseph Garland, Jennie Johnson, et al.. (2020). SARS‐CoV‐2 and HIV coinfection: clinical experience from Rhode Island, United States. Journal of the International AIDS Society. 23(7). e25573–e25573. 48 indexed citations

Ji, Hezhao, Paul Sandstrom, Roger Paredes, et al.. (2020). Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium. Viruses. 12(6). 586–586. 19 indexed citations

DeLong, Allison, et al.. (2020). Comparison of machine learning methods for predicting viral failure: a case study using electronic health record data. PubMed. 12(s1). 20190017–20190017. 1 indexed citations

Kantor, Rami, John P Fulton, Jon A. Steingrimsson, et al.. (2020). Challenges in evaluating the use of viral sequence data to identify HIV transmission networks for public health. PubMed. 12(s1). 3 indexed citations

10.

Howison, Mark, Mia Coetzer, & Rami Kantor. (2018). Measurement error and variant-calling in deep Illumina sequencing of HIV. Bioinformatics. 35(12). 2029–2035. 20 indexed citations

11.

Oyomopito, Rebecca, Yen‐Ju Chen, Somnuek Sungkanuparph, et al.. (2015). Risk group characteristics and viral transmission clusters in South‐East Asian patients infected with human immunodeficiency virus‐1 (HIV‐1) circulating recombinant form (CRF) 01_AE and subtype B. The Kaohsiung Journal of Medical Sciences. 31(9). 445–453. 2 indexed citations

12.

Coetzer, Mia, et al.. (2013). Extensive Drug Resistance in HIV-Infected Cambodian Children Who Are Undetected as Failing First-Line Antiretroviral Therapy by WHO 2010 Guidelines. AIDS Research and Human Retroviruses. 29(7). 985–992. 9 indexed citations

13.

Huang, Austin, et al.. (2012). QColors: An algorithm for conservative viral quasispecies reconstruction from short and non-contiguous next generation sequencing reads. In Silico Biology. 11(5-6). 193–201. 16 indexed citations

14.

Saravanan, Shanmugam, Vidya Madhavan, Rami Kantor, et al.. (2012). Unusual Insertion and Deletion at Codon 67 and 69 of HIV Type 1 Subtype C Reverse Transcriptase Among First-Line Highly Active Antiretroviral Treatment-Failing South Indian Patients: Association with Other Resistance Mutations. AIDS Research and Human Retroviruses. 28(12). 1763–1765. 5 indexed citations

15.

Chan, Philip A., Aadia Rana, Kenneth H. Mayer, et al.. (2012). Short Communication: New HIV Infections at Southern New England Academic Institutions: Implications for Prevention. AIDS Research and Human Retroviruses. 29(1). 25–29. 12 indexed citations

16.

Saravanan, Shanmugam, Vidya Madhavan, Pachamuthu Balakrishnan, et al.. (2012). Darunavir Is a Good Third-Line Antiretroviral Agent for HIV Type 1-Infected Patients Failing Second-Line Protease Inhibitor-Based Regimens in South India. AIDS Research and Human Retroviruses. 29(3). 630–632. 6 indexed citations

17.

DeLong, Allison, Diane Bennett, Neil Parkin, et al.. (2011). Sequence Quality Analysis Tool for HIV Type 1 Protease and Reverse Transcriptase. AIDS Research and Human Retroviruses. 28(8). 894–901. 31 indexed citations

18.

Kumarasamy, N., Vidya Madhavan, Kartik K. Venkatesh, et al.. (2009). High Frequency of Clinically Significant Mutations after First‐Line Generic Highly Active Antiretroviral Therapy Failure: Implications for Second‐Line Options in Resource‐Limited Settings. Clinical Infectious Diseases. 49(2). 306–309. 55 indexed citations

19.

Kassaye, Seble, Esther Lee, Rami Kantor, et al.. (2007). Drug Resistance in Plasma and Breast Milk after Single-Dose Nevirapine in Subtype C HIV Type 1: Population and Clonal Sequence Analysis. AIDS Research and Human Retroviruses. 23(8). 1055–1061. 27 indexed citations

20.

Kantor, Rami, Lynn S. Zijenah, Robert W. Shafer, et al.. (2002). HIV-1 Subtype C Reverse Transcriptase and Protease Genotypes in Zimbabwean Patients Failing Antiretroviral Therapy. AIDS Research and Human Retroviruses. 18(18). 1407–1413. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact